High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The objective of this study is to evaluate the impact of this HDIVC therapy in the first treatment of symptomatic Covid-19 patients in a time period of one week.
Epistemonikos ID: 6d090188ba324b07fe9a0841a1d0d5c512ebeb11
First added on: Sep 01, 2021